UN, Partners Say Bilateral Deals, Delays Hampering COVAX Deliveries

New York: While 80 percent of citizens in high and upper-middle income nations have had a dose of covid-19 vaccine, that figure stands at just 20 percent for those living below the top tiers, according to a joint statement issued by United Nations (UN) and partner agencies, responsible for the multilateral COVAX initiative to provide equal access for all. 
 
"It’s a year since the innovative scheme was born, in a bid to guarantee timely access to everyone, regardless of their income, status or location, to life-saving jabs, as the pandemic gripped the world. Yet, the global picture of access to COVID-19 vaccines is unacceptable," said the statement released on Wednesday. 
 
"In the critical months during which COVAX was created, signed on participants, pooled demand, and raised enough money to make advance purchases of vaccines, much of the early global supply had already been bought by wealthy nations," the World Health Organisation (WHO), UN Children’s Fund (UNICEF), CEPI, GAVI and other partners behind the initiative said.  

According to UN and its partners, COVAX’s ability to protect the most vulnerable people in the world continues to be hampered by export bans, the prioritisation of bilateral deals by manufacturers and countries, ongoing challenges in scaling up production by some key producers, and delays in filing for regulatory approval.
 
COVAX has already achieved significant progress: more than $10 billion has been raised; legally-binding commitments for up to 4.5 billion doses of vaccine; 240 million doses have been delivered to 139 countries in just six months.
 
But according to its latest Supply Forecast, COVAX expects to have access to around 1.425 billion doses of vaccine in 2021, in the most likely scenario and in the absence of urgent action by producers and high-coverage countries to prioritize COVAX.
 
Of these doses, approximately 1.2 billion will be available for the lower income economies participating in the so-called COVAX Advance Market Commitment (AMC). 
 
This is enough to provide protection for 20 percent of the population, or 40 percent of all adults, in all 92 AMC economies, with the exception of India. 
 
Over 200 million doses will be allocated to self-financing participants. 
 
According to COVAX, the key COVAX milestone of two billion doses released for delivery is now expected to be reached in the first quarter of 2022.
 
Cek Berita dan Artikel yang lain di Google News